Morning Overview
Science
Animals
Archeology
Astronomy
Biology
Health
Neuroscience
Technology
Commercial Aircraft
Consumer Tech
Cybersecurity
Hardware and Semiconductors
Software, Apps, and Big Tech
Space Systems
Telecom and Connectivity
AI
Military
Aviation
Ground Systems
Naval
Transportation
Aircraft
Cars
Electric Vehicles
SUV’s
Trucks
Watercraft
Energy & Climate
Climate Policy and Regulation
Energy Transition
Extreme Weather
Nuclear
Power and Grids
X
IG
FB
PIN
LI
X
Science
Animals
Archeology
Astronomy
Biology
Health
Neuroscience
Technology
Commercial Aircraft
Consumer Tech
Cybersecurity
Hardware and Semiconductors
Software, Apps, and Big Tech
Space Systems
Telecom and Connectivity
AI
Military
Aviation
Ground Systems
Naval
Transportation
Aircraft
Cars
Electric Vehicles
SUV’s
Trucks
Watercraft
Energy & Climate
Climate Policy and Regulation
Energy Transition
Extreme Weather
Nuclear
Power and Grids
X
Global Font
Science
/
Health
Health
Latest in Health
Health
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targeted drug to patients outside the trial
By
BeckhamLangford
Health
A new study just tied junk-food diets in early childhood to lasting wiring changes in the brain — damage that sticks even after kids switch back to healthy eating
By
BeckhamLangford
Health
A hormone drug already on pharmacy shelves just flipped adult nerve cells back into regrowth mode — pointing spinal-cord trials at a pill doctors already prescribe
By
BeckhamLangford
Health
A UK-led trial just beat bowel cancer into remission with nine weeks of pembrolizumab — and nearly three years later not one patient has seen the tumor come back
By
BeckhamLangford
Health
UC San Diego’s experimental pill just reversed the worst form of fatty liver disease in trial patients — shutting off the single enzyme driving fat buildup and inflammation
By
BeckhamLangford
Health
A daraxonrasib trial just held pancreatic cancer in check for 8.5 months in most patients — twice as long as standard chemo for tumors that spread after first-line treatment
By
BeckhamLangford
Health
CBD just calmed the brain’s own immune cells in a new lab study — quietly pulling the plug on the inflammation that drives Alzheimer’s disease
By
BeckhamLangford
Health
A new two-pill combo just slashed LDL cholesterol by 48.6% in a Phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
By
BeckhamLangford
Health
The first-ever drug aimed at pancreatic cancer’s ‘untreatable’ KRAS mutation just cleared the FDA’s safe-to-proceed letter — full Phase 1/2 results drop at ASCO this Sunday
By
BeckhamLangford
Health
Researchers just built a LASIK alternative that reshapes the eye without a laser — mild electrical pulses through a platinum contact lens do the work in about a minute
By
BeckhamLangford
Health
Customized mRNA vaccines built on each tumor’s genetic profile just pushed pancreatic cancer patients into remission — trial results carrying strongest signal yet for the hardest cancer
By
BeckhamLangford
Health
Drinking guava juice alongside iron supplements boosted anemia recovery by a significant margin — a 17-study review found the effect strongest in women and teenage girls
By
BeckhamLangford
Health
Drinking beetroot juice just reshaped the mouth bacteria of older adults — quietly lowering their blood pressure as a cheap vegetable does the work of a pill
By
BeckhamLangford
Health
A new study just tied junk-food diets early in life to lasting changes in the brain’s wiring — damage that sticks even after people switch back to healthy food
By
BeckhamLangford
Health
A UK-led trial just beat bowel cancer into remission with nine weeks of pembrolizumab — and nearly three years later not one patient has seen it come back
By
BeckhamLangford
Health
A single-patch sensor now reads blood sugar through the skin with no needle stick — and the first versions are already on their way to pharmacy shelves
By
BeckhamLangford
Health
UC San Diego just cracked an experimental drug that reverses the worst form of fatty liver disease in millions — blocking the single enzyme driving fat buildup and inflammation
By
BeckhamLangford
Health
A single gene-silencing shot just cut dangerous cholesterol in half for a full year — built to replace the daily statins millions of adults already take
By
BeckhamLangford
Health
A Phase 1/2 trial just reported exceptional disease control on pancreatic cancer using daraxonrasib — a targeted drug aimed at the mutation doctors once called untreatable
By
BeckhamLangford
Health
A drug combo studied for anti-aging just backfired in mice — researchers caught severe loss of the brain’s insulation, mimicking the ‘chemo brain’ it was meant to fight
By
BeckhamLangford
« Prev
1
2
3
4
…
75
Next »